Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2016-05-19 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Roadshow Asia, Singapore
Investor Presentation Classification · 98% confidence The document text is structured as a presentation, indicated by section headers like "Roadshow Singapore – May 19, 2016," "INVESTMENT HIGHLIGHTS," and numerous slides detailing business segments, financial results (Q1/2016), outlooks, and mid-term targets. The content is highly focused on presenting financial performance and strategic updates to investors. This format strongly suggests an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS). The presence of detailed segment breakdowns and forward-looking statements typical of an investor roadshow confirms the classification.
2016-05-19 English
Roadshow Asia, Hongkong
Investor Presentation Classification · 98% confidence The document text is a presentation titled 'Roadshow Hong Kong – May 18, 2016' and contains detailed financial data, segment performance updates (Fresenius Medical Care, Kabi, Helios, Vamed), Q1/2016 results, 2016 guidance, and mid-term targets. This structure—a detailed presentation used to communicate strategy and performance to investors—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief announcement of a report (RPA/RNS). The presence of 'Q1/2016' data suggests it is a quarterly update, but the format is clearly a presentation deck.
2016-05-18 English
Goldman Sachs First Annual Leveraged Finance Conference
Investor Presentation Classification · 98% confidence The document is structured as a presentation, indicated by the title 'Goldman Sachs – Leveraged Finance Conference' and the presence of slides/sections like 'Agenda', 'Company Overview', 'Business Segments', and 'Summary and Outlook'. It contains detailed financial metrics, segment breakdowns, and forward-looking guidance for the fiscal year 2016, based on Q1 2016 results and LTM March 2016 data. This format, presenting strategy, performance, and outlook to investors at a conference, strongly aligns with the definition of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement (RPA/RNS).
2016-05-17 English
Roadshow Asia, Tokyo
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow Tokyo – May 16/17, 2016' and contains extensive slides detailing the company's business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), financial results for Q1/2016, financial outlook for 2016, and mid-term growth targets (FY 2019). It includes tables with key financial metrics (Sales, EBIT, Net Income) and growth rates, characteristic of an investor presentation used during roadshows or investor days. It is not a formal regulatory filing like a 10-K or a brief earnings release (ER), but a detailed presentation package for investors. Therefore, it fits the Investor Presentation (IP) category.
2016-05-16 English
Hauptversammlung 2016, Fresenius Rede CEO
AGM Information Classification · 100% confidence The document is titled "Hauptversammlung der Fresenius SE & Co. KGaA am 13. Mai 2016" (Annual General Meeting of Fresenius SE & Co. KGaA on May 13, 2016) and contains the speech of the CEO, Dr. Ulf M. Schneider. It reviews the 2015 results, discusses the proposed dividend increase, outlines stability factors, and provides an outlook for 2016 and medium-term goals. The content is clearly material presented or discussed during an Annual General Meeting (AGM). This aligns perfectly with the definition for AGM Information (AGM-R).
2016-05-13 German
Hauptversammlung 2016, Fresenius Präsentation
AGM Information Classification · 99% confidence The document explicitly states in the title and footer: "Annual General Meeting Fresenius SE & Co. KGaA" and is dated May 13, 2016. It contains performance highlights (sales, EBIT, net income) and strategic segment reviews, which are typical materials presented or distributed at an AGM. This directly corresponds to the AGM Information category.
2016-05-13 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.